| Description | BMS-813160 is the first dual CCR2/CCR5 antagonist to enter Clinical development for cardiovascular. |
| Synonyms | BMS 813160 |
| molecular weight | 484.64 |
| Molecular formula | C25H40N8O2 |
| CAS | 1286279-29-5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 55 mg/mL (113.49 mM) |
| References | 1. Norman P. et al. A dual CCR2/CCR5 chemokine antagonist, BMS-813160? Evaluation of WO2011046916. Expert Opin Ther Pat. 2011 Dec;21(12):1919-24. |